9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Estimated reading time: < 1 min

Condition: Advanced Malignant Mesothelioma

Estimated Enrollment: 106

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Time to disease progression,  Complete response rate,  Objective response rate (complete and partial response), Rate of disease stabilization

Interventions: gemcitabine hydrochloride, cisplatin

Phase:

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double,Primary Purpose: Treatment

Primary Completion Date: May 2006

Completion Date:

Last  Posted Date: February 11, 2014

Location: University of Chicago, Chicago, Illinois, United States

Website Link: https://ClinicalTrials.gov/show/NCT00027703

Was this article helpful?
Dislike 0